An international team of gene experts has identified a mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells.
Monthly Archive: November 2014
Teen driving safety researchers suspect there is a surprising lack of rigorous scientific studies focusing on teen drivers with ADHD, according to Allison Curry, PhD, at The Children’s Hospital of Philadelphia.
A study conducted by PolicyLab researchers shows the proportion of US-born, Medicaid-enrolled children in Pennsylvania who utilized preventive dental care rose significantly for children ages 5-10.
Bone marrow failure syndromes are rare disorders in which the bone marrow does not produce enough blood cells, increasing the risk for life-threatening bleeding, anemia, and infections.
The Children’s Hospital of Philadelphia’s Sriram Krishnaswamy, PhD, is set to deliver this year’s Sol Sherry Distinguished Lecture in Thrombosis at this week’s American Heart Association Scientific Sessions annual conference.
Genomic scientists at The Children’s Hospital of Philadelphia found strong evidence that the protein family, FOXA2, is a master regulator of genetically vulnerable pathways in multiple diseases.
A pediatric brain tumor expert and Deputy Scientific Director of the Research Institute, Dr. Curran was one of seventeen volunteers appointed to the PBTF’s newly created Research Advisory Network.
The Autism Roadmap is a new website developed entirely as a result of philanthropy and with the expertise of nearly a dozen of the nation’s top autism experts at The Center for Autism Research (CAR) at The Children’s Hospital of Philadelphia.
A new study from the Center for Injury Research and Prevention provides evidence that New Jersey’s Graduated Driver Licensing (GDL) decal provision is associated with a sustained decline in crash rates among provisional teen drivers.
An international team of researchers recently identified gene mutations that can cause severe, difficult-to-treat forms of childhood epilepsy. Many of the mutations disrupt functioning in the synapse, the highly dynamic junction at which nerve cells communicate with one another.